Clinical Trials | March 17, 2026
Eli Lilly’s EBGLYSS shows breakthrough results in children with severe eczema
The company announced positive topline data from the Phase 3 ADorable-1 trial
The company announced positive topline data from the Phase 3 ADorable-1 trial
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
There are limited treatment options available for patients living with non-diabetic CKD, and the unmet need is high for new treatments to delay kidney disease progression and reduce cardiovascular risk
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The product is bioequivalent and therapeutically equivalent to Fresenius Kabi’s reference drug (NDA 212832)
Subscribe To Our Newsletter & Stay Updated
